Jan 26, 2022 05:47 PM
PODCAST
Caixin China Biz Roundup: Chinese mRNA Jab Activates 80% to 95% Immune Response
Jan.26.2022
Behind the findings of the homegrown shot’s first stage clinical trials; Beijing’s plan to stay smog-free over the Olympics; and China digests a record amount of bad assets
00:00/00:00
Contact senior podcast producer Nandini Venkata （nandinivenkata@caixin.com）
Download our app to receive breaking news alerts and read the news on the go.
Get our weekly free Must-Read newsletter.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1Cover Story: Why Modi Won’t Play Cowboys and Indians With Trump, Opting Instead for Strategic Autonomy
- 2China, U.S. to Meet in Spain Over TikTok, Trade Disputes
- 3Weekend Long Read: Tycoon’s Eight-Hour Escape Exposes Failings of a Model Chinese Prison
- 4Carlyle, HongShan, EQT Among Final Contenders for Starbucks’ China Business
- 5Chinese Ex-Employee of U.S. Hedge Fund Two Sigma Faces Fraud Charges
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas
Sign in with Google
Sign in with Facebook
Sign in with 财新